Compounds and methods of targeting interleukin-34

The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for the treatment of immune-mediated diseases, such as neurodegenerative diseases, such as Alzheimer's disease or Tauopathy diseases. 本公开内容涉及IL-3...

Full description

Saved in:
Bibliographic Details
Main Authors SCOLA, ANDREW, DAVID, MINTHONG MILIND, WEST ERIC ANTHONY, LOO ALEXANDER, SIMS, JOHN, R., II, WALSH, RICHARD, E, CHEAD MICHAEL, FLEISCHER AMY S, RANNAN MANISH BABU, RAINES, SCOTT, E, OBUNGU VICTOR H, YE, MING
Format Patent
LanguageChinese
English
Published 09.08.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for the treatment of immune-mediated diseases, such as neurodegenerative diseases, such as Alzheimer's disease or Tauopathy diseases. 本公开内容涉及IL-34抗体、包含其的组合物以及使用所述抗体和或其组合物用于治疗诸如神经变性疾病的免疫介导的疾病的方法，例如阿尔茨海默病或Tau蛋白病变疾病。
Bibliography:Application Number: CN20228086946